Related Experiment Video
Updated: Sep 10, 2025
09:16
Supervised Machine Learning for Semi-Quantification of Extracellular DNA in Glomerulonephritis
Published on: June 18, 2020
7.0K
Integrating Multi-Omics Data Using Machine Learning to Explore New Therapeutic Targets for Acute Kidney Injury
Qiming Gong1,2, Yakun Wang3,4, Fahui Liu5
1Department of Nephrology, Affiliated Hospital of Youjiang Medical University for Nationalities, Baise, China.
Journal of Cellular and Molecular Medicine
|August 27, 2025
Summary
Renal ischemia-reperfusion (I/R) injury, a complication of kidney transplants, lacks targeted treatments. This study identifies ADAMTS1 as a key factor in I/R-induced acute kidney injury (I/R-AKI) and shows troglitazone can mitigate damage.
Area of Science:
- Nephrology
- Molecular Biology
- Bioinformatics
Background:
- Renal ischemia-reperfusion (I/R) injury is a significant complication in renal transplantation, leading to acute kidney injury (AKI).
- Current therapeutic strategies for I/R-AKI are limited, necessitating the identification of novel molecular targets and diagnostic tools.
Purpose of the Study:
- To elucidate the molecular mechanisms underlying I/R-induced AKI (I/R-AKI) at the single-cell level.
- To identify potential therapeutic targets and develop diagnostic models for I/R-AKI.
- To evaluate the efficacy of pharmacological agents in mitigating I/R-AKI.
Main Methods:
- Bioinformatic analysis of single-cell data to identify critical genes in I/R-AKI.
- Development and validation of a diagnostic model for I/R-AKI.
- Experimental validation using immunofluorescence, western blotting, immunohistochemistry, and transmission electron microscopy in I/R mouse models and human AKI samples.
- Assessment of troglitazone's effect on ADAMTS1 expression and I/R-AKI pathology.
Main Results:
- A robust diagnostic model for I/R-AKI was developed and validated.
- ADAMTS1 was identified as a promoter of renal I/R-AKI, significantly upregulated in renal tubular epithelial cells.
- Mitochondrial pathway-mediated apoptosis was confirmed as a critical factor in I/R injury progression.
- Inhibition of ADAMTS1 by troglitazone significantly reduced functional and histological damage in I/R-AKI mouse models.
Conclusions:
- ADAMTS1 plays a crucial role in promoting renal I/R-AKI.
- The developed diagnostic model is valuable for I/R-AKI diagnosis.
- Troglitazone demonstrates therapeutic potential for I/R-AKI by inhibiting ADAMTS1 expression, offering insights for future treatment strategies.
Related Concept Videos
01:22Acute Kidney Injury I: Introduction
72
Introduction:Acute Kidney Injury (AKI) describes a swift decrease in kidney function occurring over hours to days, characterized by the kidneys' failure to remove waste products from the bloodstream. This leads to dangerous complications like metabolic acidosis, fluid overload, and electrolyte imbalances, such as hyperkalemia, which can cause life-threatening arrhythmias. AKI is common in both hospital and outpatient settings, often triggered by dehydration, sepsis, or exposure to nephrotoxic...
72
01:30Acute Kidney Injury IV: Diagnostic Studies and Prevention
57
Accurate diagnosis and effective prevention are critical in managing Acute Kidney Injury (AKI), which is linked to high mortality rates ranging from 10% to 80%. Timely recognition of at-risk patients and careful monitoring can significantly reduce the likelihood of kidney damage.Diagnostic Assessments:The diagnostic process starts with a comprehensive medical history to identify prerenal, intrarenal, and postrenal causes.Prerenal causes, such as dehydration, hypotension, or blood loss, should...
57
01:29Acute Kidney Injury II: Pathophysiology
72
Acute kidney injury (AKI) causes are categorized into three primary categories based on the location of the injury: prerenal, intrarenal (or intrinsic), and postrenal causes. This classification guides clinical management and illustrates how different pathways can impair kidney function.Etiology and Pathophysiology of Acute Kidney Injury1. Prerenal causesEtiology: Prerenal Acute Kidney Injury, the most common type, occurs when reduced blood flow to the kidneys decreases filtration capacity...
72
01:20Acute Kidney Injury V: Interprofessional Care
44
Acute Kidney Injury (AKI) requires a collaborative healthcare approach to restore renal function and prevent complications. Essential management strategies involve monitoring fluid and electrolyte balance, adjusting medications, initiating dialysis when necessary, and providing nutritional support.Fluid and Electrolyte ManagementFluid Monitoring: Regularly monitoring body weight, central venous pressure, and urine output helps detect fluid imbalances early. Patient intake and output are...
44
01:29Acute Kidney Injury III: Clinical Manifestations
90
Acute Kidney Injury (AKI) progresses through distinct clinical phases: the oliguric, diuretic, and recovery phases, each marked by unique manifestations and challenges.Oliguric Phase:The oliguric phase is the initial stage of AKI, typically lasting 10 to 14 days. This phase is marked by a significant reduction in urine output, usually less than 400 mL per day, indicating decreased kidney function. Fluid retention is a prominent feature, leading to symptoms such as edema, hypertension, and...
90
01:22Acute Kidney Injury VI: Nursing Management
57
Acute Kidney Injury (AKI) results in an inability to maintain fluid, electrolyte, and acid-base balance. Effective nursing management is critical in improving patient outcomes and includes comprehensive patient assessment and targeted interventions.Comprehensive Patient AssessmentA detailed history collection is essential, focusing on any recent infections, nephrotoxic medication use, or chronic conditions such as hypertension and diabetes that may contribute to AKI. During the physical...
57